Cisplatin-Loaded Tobacco Mosaic Virus for Ovarian Cancer Treatment.


Journal

Biomacromolecules
ISSN: 1526-4602
Titre abrégé: Biomacromolecules
Pays: United States
ID NLM: 100892849

Informations de publication

Date de publication:
10 Oct 2022
Historique:
pubmed: 3 9 2022
medline: 12 10 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

Ovarian cancer is the foremost cause of gynecological cancer and a major cause of cancer death in women. Treatment for advanced stage is surgical debulking followed by chemotherapy; however, most patients relapse with more aggressive and therapy-resistant tumors. There is a need to develop drug delivery approaches to deliver platinum therapies to tumors to increase efficacy while maintaining safety. Toward this goal, we utilized the protein nanotubes from the plant virus, tobacco mosaic virus (TMV), as a drug carrier. Specifically, the nanochannel of TMV was loaded with the active dication form of cisplatin (cisPt

Identifiants

pubmed: 36053908
doi: 10.1021/acs.biomac.2c00831
pmc: PMC9831511
mid: NIHMS1860385
doi:

Substances chimiques

Drug Carriers 0
Vascular Endothelial Growth Factor A 0
Platinum 49DFR088MY
Cisplatin Q20Q21Q62J

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4379-4387

Subventions

Organisme : NCI NIH HHS
ID : R01 CA224605
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA253615
Pays : United States

Références

Eur J Cancer. 2004 Jan;40(2):291-7
pubmed: 14728945
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Nat Nanotechnol. 2016 Mar;11(3):295-303
pubmed: 26689376
Virology. 2014 Jan 20;449:163-73
pubmed: 24418549
Mol Pharm. 2014 Apr 7;11(4):1239-49
pubmed: 24621456
Philos Trans R Soc Lond B Biol Sci. 1999 Mar 29;354(1383):531-5
pubmed: 10212932
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Sep;8(5):776-91
pubmed: 26848041
Oncogene. 2012 Apr 12;31(15):1869-83
pubmed: 21892204
Adv Healthc Mater. 2022 Jun;11(12):e2200163
pubmed: 35184421
J Control Release. 2003 May 20;89(3):397-408
pubmed: 12737842
Nat Nanotechnol. 2013 Oct;8(10):763-71
pubmed: 24077028
J Am Chem Soc. 2005 Mar 23;127(11):3718-23
pubmed: 15771505
Cancer Immunol Immunother. 2010 Feb;59(2):293-301
pubmed: 19690855
Int J Mol Sci. 2017 Jun 10;18(6):
pubmed: 28604595
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Mol Pharm. 2020 Dec 7;17(12):4629-4636
pubmed: 33186039
Proc Natl Acad Sci U S A. 2013 Jun 25;110(26):10753-8
pubmed: 23754411
Nanoscale. 2018 Aug 30;10(34):16307-16313
pubmed: 30129956
Hematol Oncol Clin North Am. 2019 Apr;33(2):261-274
pubmed: 30832999
ACS Macro Lett. 2014 Jul 15;3(7):602-606
pubmed: 25419487
Clin Pharmacol Ther. 2011 Apr;89(4):491-502
pubmed: 21368752
J Control Release. 2022 Jul;347:425-434
pubmed: 35569588
ACS Omega. 2018 Apr 30;3(4):3702-3707
pubmed: 29732445
Acta Biomater. 2015 Jun;19:166-79
pubmed: 25769228
Chemistry. 2018 Oct 22;24(59):15706-15724
pubmed: 29572992
ACS Nano. 2016 Apr 26;10(4):4119-26
pubmed: 26982250
Metallomics. 2011 Jan;3(1):49-55
pubmed: 21135941
Radiol Oncol. 2019 Mar 28;53(2):148-158
pubmed: 30956230
Nanoscale. 2013 May 7;5(9):3808-16
pubmed: 23519401
Acta Biomater. 2019 Sep 15;96:55-67
pubmed: 31152941
Biomaterials. 2010 Mar;31(8):2034-42
pubmed: 20044133
Adv Healthc Mater. 2015 Apr 22;4(6):874-82
pubmed: 25641794
Chem Rev. 1999 Sep 8;99(9):2467-98
pubmed: 11749487
Mol Pharm. 2018 Sep 4;15(9):3700-3716
pubmed: 29798673
J Pharm Sci. 2009 Jul;98(7):2299-316
pubmed: 19009590
Biotechnol J. 2020 Dec;15(12):e2000077
pubmed: 32918857
Mol Pharm. 2018 Aug 6;15(8):2922-2931
pubmed: 28926265
Toxicol Sci. 2013 Jan;131(1):13-25
pubmed: 23019274
Biomater Sci. 2020 Jul 21;8(14):3935-3943
pubmed: 32662788
Clin Cancer Res. 2008 Mar 1;14(5):1310-6
pubmed: 18316549
ACS Biomater Sci Eng. 2016 May 9;2(5):838-844
pubmed: 28713855
Br J Cancer. 2006 Oct 9;95(7):822-8
pubmed: 16969346
Cancer Chemother Pharmacol. 1987;20(3):211-2
pubmed: 2824080
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7606-11
pubmed: 8755522
Nat Rev Cancer. 2010 Feb;10(2):147-56
pubmed: 20075923
Curr Opin Chem Biol. 2017 Jun;38:108-116
pubmed: 28426952
Int J Surg Oncol. 2012;2012:862879
pubmed: 22778941
Bioorg Chem. 2019 Jul;88:102925
pubmed: 31003078
Mol Ther. 2008 Aug;16(8):1450-8
pubmed: 18560419
Methods Mol Biol. 2014;1108:173-85
pubmed: 24243249

Auteurs

Zhongchao Zhao (Z)

Department of NanoEngineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
Center for Nano-ImmunoEngineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.

Andrea Simms (A)

Department of NanoEngineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.

Nicole F Steinmetz (NF)

Department of NanoEngineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
Center for Nano-ImmunoEngineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
Department of Bioengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
Department of Radiology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
Institute for Materials Discovery and Design, University of California, 9500 Gilman Drive, La Jolla, California 92093, United States.
Moores Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH